Prediction of Pharmacokinetics Prior to In Vivo Studies. II. Generic Physiologically Based Pharmacokinetic Models of Drug Disposition-Reference-Cited by-同舟云学术

Prediction of Pharmacokinetics Prior to In Vivo Studies. II. Generic Physiologically Based Pharmacokinetic Models of Drug Disposition

Published:2002-05 Issue:5 Volume:91 Page:1358-1370
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Poulin Patrick,Theil Frank-Peter

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference27 articles.

1. Pharmacokinetics in applications of the artificial kidney;Dedrick;Chem Eng Progr Symp Ser,1969

2. Physiologically based pharmacokinetic modeling in toxicology;Krishnan,2001

3. Physiologically based pharmacokinetic model of primidone and its metabolites phenobarbital and phenylethylmalonamide in humans, rats, and mice;El-Masri;Drug Metab Dispos,1998

4. Research to develop a predicting system of mammalian subacute toxicity. III. Construction of a predictive toxicokinetic model;Yamaguchi;Chemosphere,1996

5. Quantitative structure-pharmacokinetic relationships. I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat;Blakey;J Pharmacokinet Biopharm,1997

Cited by 270 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Physiologically based pharmacokinetic model analysis of the inhibitory effect of vonoprazan on the metabolic activation of proguanil;Drug Metabolism and Pharmacokinetics;2024-02

2. Advances in physiologically based modeling coupled with in vitro-in vivo extrapolation of ADMET: Assessing the impact of genetic variability in hepatic transporters;Encyclopedia of Toxicology;2024

3. Physiologically based pharmacokinetic (PBPK) modeling to predict the pharmacokinetics of irbesartan in different CYP2C9 genotypes;Archives of Pharmacal Research;2023-12

4. The Interplay of Permeability, Metabolism, Transporters, and Dosing in Determining the Dynamics of the Tissue/Plasma Partition Coefficient and Volume of Distribution—A Theoretical Investigation Using Permeability-Limited, Physiologically Based Pharmacokinetic Modeling;International Journal of Molecular Sciences;2023-11-12

5. Estimation of volatile organic compound exposure concentrations and time to reach a specific dermal absorption using physiologically based pharmacokinetic modeling;Journal of Occupational and Environmental Hygiene;2023-09-12